The early benefit assessment in the context of the Act on the Reform of the Market for Medicinal Products (AMNOG)

A critical analysis from the perspective of the stakeholders at the end of the 17th legislative period

Nonfiction, Health & Well Being, Health
Cover of the book The early benefit assessment in the context of the Act on the Reform of the Market for Medicinal Products (AMNOG) by Sara Schlenkrich, GRIN Verlag
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Sara Schlenkrich ISBN: 9783656766018
Publisher: GRIN Verlag Publication: October 10, 2014
Imprint: GRIN Verlag Language: English
Author: Sara Schlenkrich
ISBN: 9783656766018
Publisher: GRIN Verlag
Publication: October 10, 2014
Imprint: GRIN Verlag
Language: English

Bachelor Thesis from the year 2013 in the subject Health Science, grade: 1,4, Neisse University Görlitz, course: V282129, language: English, abstract: The Act on the Reform of the Market for Medicinal Products, which entered into force on the 1st of January 2011, brought about a fundamental change in the balance of power on the pharmaceutical market. This thesis therefore sets out to answer the following question: What impact does the early benefit assessment in the context of the Act on the Reform of the Market for Medicinal Products have on the stakeholders of the healthcare system? To answer this question, this work first presents the theoretical foundations of the law, of the early benefit assessment and the bodies involved. It then takes stock of the decisions taken to date before describing the impact on the selected stakeholders. The following findings were reached: As the representative of the statutory health insurance funds, the Central Federal Association of Statutory Health Insurance Funds has gained in power and now decides, as a member of the Federal Joint Committee, on the added benefit of a drug and, depending on this decision, also on the future reimbursement rate. Pharmaceutical companies, however, are losing clout and must comply with the guidelines and assessments of the early benefit assessment. Patients stand to gain and lose out from the early benefit assessment. They are the ones who are ultimately dependent on the medicinal product and its improvement and benefit from a proven benefit. However, they have no say in the early benefit assessment procedure.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Bachelor Thesis from the year 2013 in the subject Health Science, grade: 1,4, Neisse University Görlitz, course: V282129, language: English, abstract: The Act on the Reform of the Market for Medicinal Products, which entered into force on the 1st of January 2011, brought about a fundamental change in the balance of power on the pharmaceutical market. This thesis therefore sets out to answer the following question: What impact does the early benefit assessment in the context of the Act on the Reform of the Market for Medicinal Products have on the stakeholders of the healthcare system? To answer this question, this work first presents the theoretical foundations of the law, of the early benefit assessment and the bodies involved. It then takes stock of the decisions taken to date before describing the impact on the selected stakeholders. The following findings were reached: As the representative of the statutory health insurance funds, the Central Federal Association of Statutory Health Insurance Funds has gained in power and now decides, as a member of the Federal Joint Committee, on the added benefit of a drug and, depending on this decision, also on the future reimbursement rate. Pharmaceutical companies, however, are losing clout and must comply with the guidelines and assessments of the early benefit assessment. Patients stand to gain and lose out from the early benefit assessment. They are the ones who are ultimately dependent on the medicinal product and its improvement and benefit from a proven benefit. However, they have no say in the early benefit assessment procedure.

More books from GRIN Verlag

Cover of the book Europäische Union und deutsches Strafrecht by Sara Schlenkrich
Cover of the book Social Organization and Self-Government of Albanians according to the Costumary Law by Sara Schlenkrich
Cover of the book Cloud Computing und Datenschutz by Sara Schlenkrich
Cover of the book Analyse von 'Das erschöpfte Selbst: Depression und Gesellschaft in der Gegenwart' von Alain Ehrenberg by Sara Schlenkrich
Cover of the book Auswirkungen der Familie auf die Bildungschancen der Kinder by Sara Schlenkrich
Cover of the book Was ist Seele? by Sara Schlenkrich
Cover of the book Umsatzsteuer bei Kreditinstituten by Sara Schlenkrich
Cover of the book Planung, Durchführung und Reflexion einer Unterrichtsstunde 'Special Days in Britain' by Sara Schlenkrich
Cover of the book Medien im Alltag von Kindern by Sara Schlenkrich
Cover of the book Alzheimer - Therapiemöglichkeiten mit Zukunft by Sara Schlenkrich
Cover of the book Motivation, Klassenführung, Unterrichtserfolg - Praktikumsbericht über das studienbegleitende fachdidaktische Praktikum by Sara Schlenkrich
Cover of the book Populärer Islam by Sara Schlenkrich
Cover of the book Die konfessionsverschiedene Ehe by Sara Schlenkrich
Cover of the book Die Entwicklung des Risikostrukturausgleichs - Eine kritische Analyse des Finanzausgleichs in der gesetzlichen Krankenversicherung by Sara Schlenkrich
Cover of the book Betrachtung des Krieges in der Modernisierungstheorie by Sara Schlenkrich
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy